Vanguard Portfolio Management
ROIV icon

Vanguard Portfolio Management’s Roivant Sciences ROIV Stock Holding History

Vanguard Portfolio Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$792M Buy
21,657,255
+15,916
+0.1% +$577K 0.04% 489
2026
Q2 		$766M Buy
21,641,339
+1,802,641
+9% +$53.3M 0.03% 530
2026
Q1 		$550M Buy
+19,838,698
New +$510M 0.03% 625

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Patient Square Capital
Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return

Vanguard Portfolio Management's ROIV Position: Q3 2026 in Review

Vanguard Portfolio Management increased its Roivant Sciences (ROIV) stake by 0.07% in Q3 2026, buying an estimated $577K and bringing the position to 21,657,255 shares worth $792M. The position accounts for 0.04% of the portfolio, ranked #489.

Vanguard Portfolio Management first reported a position in ROIV in Q1 2026 and has held it in 3 quarters since. 395 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Vanguard Portfolio Management held 21,657,255 shares of Roivant Sciences worth $792M as of Q3 2026.
  • Vanguard Portfolio Management bought 15,916 Roivant Sciences shares in Q3 2026, an estimated $577K.
  • Roivant Sciences made up 0.04% of Vanguard Portfolio Management's portfolio in Q3 2026, its #489 holding.
  • Vanguard Portfolio Management first reported a position in Roivant Sciences in Q1 2026 and has held it in 3 quarters since.
  • 395 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.